Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer

Qianli Ma, Deruo Liu, Yongqing Guo, Bin Shi, Yanchu Tian, Zhiyi Song, Zhenrong Zhang, Bingsheng Ge, Xiaofei Wang, Thomas A. D’AmicoJournal of Cardiothoracic Surgery 2013 · DOI

Abstract

Pulmonary artery resection and reconstruction is feasible and safe, with favorable long-term survival. Our results support this technique as an effective alternative to selected patients with infiltration of the pulmonary artery, such as stage I and II and those who proved down-staged from stage III. Accurate preoperative evaluation, precise and suitable surgical techniques are crucial to achieve good results. Only preserving the anterior and apical pulmonary arteries and reconstruction of the main pulmonary artery by using the artery conduit technique without cardiopulmonary bypass in association with left pneumonectomy can be performed successfully. Postoperative anticoagulation is unnecessary.

Introduction

In central non-small cell lung cancer (NSCLC), tumors frequently infiltrate the pulmonary artery (PA), the vital vessel transporting deoxygenated blood to the lungs. Historically, the standard surgical response was pneumonectomy—the complete removal of a lung—to ensure an R0 resection (complete tumor removal). However, pneumonectomy is a high-risk procedure associated with significant mortality and long-term morbidity. This study explores pulmonary artery reconstruction as a lung-sparing alternative, evaluating its safety and long-term oncological outcomes over a 21-year period.

Methods

Researchers at the China-Japan Friendship Hospital conducted a retrospective review of 118 NSCLC patients who underwent PA reconstruction between 1990 and 2011. The cohort included 87 men and 28 women, with a mean follow-up of 70 months for 94 cases.

Surgical techniques were categorized into four primary approaches based on the extent of arterial involvement:

  1. Tangential Resection: Direct suturing for involvement of less than 30% of the artery wall.
  2. Patch Reconstruction: Utilizing autologous pericardium to repair the vessel when 30–50% was invaded.
  3. Sleeve Resection: Full circumferential removal and re-anastomosis for involvement exceeding 50%.
  4. Temporary Intra-Artery Conduit: A specialized technique to maintain blood flow during complex repairs without cardiopulmonary bypass.
Schematic representation of the four surgical techniques for pulmonary artery reconstruction: (A) Tangential resection, (B) Patch reconstruction, (C) Sleeve resection, and (D) Temporary intra-artery conduit.

Additionally, the study examined the "double sleeve" procedure, combining PA reconstruction with bronchial sleeve resection to maximize lung preservation. Specific technical maneuvers, such as resecting along the vertical axis and repairing along the horizontal axis, were employed to ensure vessel patency.

Detailed view of the left main pulmonary artery wall resection along the vertical axis and primary repair along the horizontal axis.

Results

The study demonstrated that PA reconstruction is oncologically safe and technically feasible. Key findings include:

  • Survival Rates: The overall 5-year survival rate was 50.2%. Stage-specific analysis showed 63.9% survival for Stages I and II, and 37.0% for Stage III.
  • Surgical Success: R0 resection was achieved in 100% of cases, with zero in-hospital mortality.
  • Prognostic Factors: Interestingly, the "double sleeve" procedure was a positive prognostic factor, suggesting that aggressive reconstruction is preferable to radical removal. Conversely, non-squamous cell carcinoma and Stage III disease were negative prognostic indicators.
  • Postoperative Care: The study found that postoperative anticoagulation was unnecessary, simplifying the recovery process.

Discussion and Conclusion

Pulmonary artery reconstruction offers a viable, lung-sparing alternative to pneumonectomy for central NSCLC. By avoiding the high stakes of radical lung removal, patients maintain better quality of life without compromising survival. The use of temporary conduits allows for complex repairs without the risks of a heart-lung machine.

While limited by its retrospective nature and the evolution of staging protocols over two decades, the study provides strong evidence for the efficacy of these techniques. Future prospective trials are needed to further refine patient selection and compare outcomes directly against pneumonectomy.

Summary updated

Abstract

Pulmonary artery resection and reconstruction is feasible and safe, with favorable long-term survival. Our results support this technique as an effective alternative to selected patients with infiltration of the pulmonary artery, such as stage I and II and those who proved down-staged from stage III. Accurate preoperative evaluation, precise and suitable surgical techniques are crucial to achieve good results. Only preserving the anterior and apical pulmonary arteries and reconstruction of the main pulmonary artery by using the artery conduit technique without cardiopulmonary bypass in association with left pneumonectomy can be performed successfully. Postoperative anticoagulation is unnecessary.
BibTeX
@article{ma2013surgical,
  author = {Qianli Ma and Deruo Liu and Yongqing Guo and Bin Shi and Yanchu Tian and Zhiyi Song and Zhenrong Zhang and Bingsheng Ge and Xiaofei Wang and Thomas A. D’Amico},
  title = {{Surgical techniques and results of the pulmonary artery reconstruction for patients with central non-small cell lung cancer}},
  journal = {Journal of Cardiothoracic Surgery},
  year = {2013},
  doi = {10.1186/1749-8090-8-219},
}
Figure